House
Tom Price
—
Transactions
283
Total transactions associated with this filer
Disclosed purchases
162
$947.2K – $4.0M
Average modeled return
+247.0%
83 of 162 purchases modeled
Average vs. S&P 500
-89.8%
Comparable modeled intervals
MODELED PERFORMANCE
Disclosed purchases vs. S&P 500
12 most recent modeled purchases. The summary and table include all modeled purchases.
MARKET ANALYSIS
Modeled purchase performance · Since purchase
83 of 162 disclosed purchases have modeled returns for this period. 79 purchases have missing or excluded market data; no returns are invented for them.
| Ticker↑↓ | Asset↑↓ | Entry↑↓ | Latest↑↓ | Modeled return↑↓ | S&P 500↑↓ | Relative↑↓ |
|---|---|---|---|---|---|---|
| VC | VISTEON CORP | Oct 21, 2014 | Nov 6, 2026 | +43.2% | +362.4% | -319.2% |
| SIG | SIGNET JEWELERS LTD | Jan 29, 2015 | Nov 6, 2026 | +17.8% | +341.8% | -324.0% |
| BIIB | BIOGEN INC. | Mar 17, 2016 | Nov 6, 2026 | +0.8% | +327.3% | -326.4% |
| AA | Alcoa Corp | Jan 29, 2015 | Nov 6, 2026 | +11.3% | +341.8% | -330.5% |
| NKE | NIKE, Inc. | Mar 17, 2016 | Nov 6, 2026 | -29.0% | +327.3% | -356.2% |
| PII | Polaris Inc. | Jan 23, 2015 | Nov 6, 2026 | -35.6% | +335.4% | -370.9% |
| PCG | PG&E Corp | Mar 31, 2016 | Nov 6, 2026 | -76.8% | +323.2% | -400.0% |
| XRX | Xerox Holdings Corp | Mar 17, 2016 | Nov 6, 2026 | -92.5% | +327.3% | -419.8% |
DISCLOSED ACTIVITY
Recent transaction history
Showing up to 25 records per page · Page 7 of 12 · 283 total transactions
| Ticker↑↓ | Asset↑↓ | Date↑↓ | Type↑↓ | Disclosed amount↑↓ | Source |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | Oct 21, 2014 | sale | $1.0K – $15.0K | Filing ↗ |
| — | Janus Asp Ovrs SS | Dec 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| — | IVY VIP Int Core Eq | Dec 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| — | IVY VIP High Inc | Dec 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| EFA | iShares MSCI EAFE ETF | Dec 14, 2015 | sale | $15.0K – $50.0K | Filing ↗ |
| NEAR | IShares Short Maturity Bond | May 13, 2015 | sale | $1.0K – $15.0K | Filing ↗ |
| IWP | iShares Russell Mid-Cap Growth ETF | Dec 7, 2015 | purchase | $15.0K – $50.0K | Filing ↗ |
| IWN | iShares Russell 2000 Value ETF | Jul 30, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| IWO | IShares Russell 200 Growth ETF | Jul 30, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| USMV | g fedcF ILINg S TATUS : New S UBHOLDINg O F : Inherited Brokerage Account SP iShares MSCI USA Min Vol Factor ETF | Jun 16, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| HYG | iShares iBoxx $ High Yield Corporate Bond ETF | Dec 10, 2015 | sale | $1.0K – $15.0K | Filing ↗ |
| — | INV VI Small Equity | Dec 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| INXN | Interxion Holding NV | Jan 29, 2015 | sale | $1.0K – $15.0K | Filing ↗ |
| INXN | Interxion Holding | Oct 21, 2014 | purchase | $1.0K – $15.0K | Filing ↗ |
| — | Innate Immunotherapeutics, Ltd. | Aug 31, 2016 | purchase | $50.0K – $100.0K | Filing ↗ |
| — | Innate Immunotherapeutics Ltd | Jan 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| — | Innate Immunotherapeutics Ltd | Jan 8, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| — | Innate Immunotherapeutics Ltd | Jan 8, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| HUB.B | Hubbell Inc B | Jan 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| HUBB | HUBBELL INC | Mar 17, 2016 | sale | $1.0K – $15.0K | Filing ↗ |
| HPQ | HP INC | Mar 17, 2016 | purchase | $1.0K – $15.0K | Filing ↗ |
| HON | HONEYWELL INTERNATIONAL INC | Oct 21, 2014 | purchase | $1.0K – $15.0K | Filing ↗ |
| HON | HONEYWELL INTERNATIONAL INC | Jan 23, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| HON | HONEYWELL INTERNATIONAL INC | Mar 17, 2016 | sale | $1.0K – $15.0K | Filing ↗ |
| HP | Helmerich & Payne, Inc. | Jan 29, 2015 | sale | $1.0K – $15.0K | Filing ↗ |
ANNUAL REPORTING
Annual financial disclosures
| Year | Document | Assets parsed | Status | Source |
|---|
No annual disclosure is currently associated with this filer.
Modeled market performance is calculated from public disclosure dates and historical market prices. It does not represent verified execution prices, realized investment returns, or investment advice. Read the modeling methodology · Review data sources and coverage · Explore other politicians